The UK Health Security Agency (UKHSA) has released a new tool that will help research and development efforts of diagnostics, vaccines, and treatments for pathogens that pose the greatest risk to public health.
Prof Dr Regina Fluhrer from the LMU & DZNE in Munich and Prof Dr Bernd Schröder from the TU in Dresden, Germany, explain how intramembrane proteases contribute to the proper development of immune cells.
Dr Leonard E.G. Mboera discusses the importance of studying emerging and vector-borne diseases at The Southern African Centre for Infectious Disease Surveillance.
Professor Iain Chapple from the University of Birmingham UK, explains the link between periodontitis and non-communicable diseases such as Type 2 diabetes
The Animal and Plant Health Inspection Service has a wide-ranging mission that includes protecting and promoting U.S. agricultural health, as this article by Open Access Government Editor, Jonathan Miles uncovers.
Dr Ahlke Heydemann, Associate Professor and Director of Medical School Curriculum at University of Illinois, Chicago explains Duchenne muscular dystrophy (DMD), focussing on the issue of correcting the dystrophin gene
Why starting at the beginning is so important in paediatric haematology research in the UK is a point impressed on us by Dr Sujith Samarasinghe at Great Ormond Street Hospital, London and Grazina Berry, CEO of the Aplastic Anaemia Trust.
Prof Colin J Suckling OBE DSc FRSE, Research Professor of Chemistry at the University of Strathclyde imparts his expertise on the worldwide research challenge of infectious disease and argues that this is both diverse and everywhere
SocialDiabetes is participating in two NHS testbed projects to pilot the future of digital health and patient-centric diabetes care, as Ikuska Sanz, the firm’s Director of Operations describes
Regina Fluhrer from the LMU & DZNE in Munich explains an aspect of health research that concerns how proteases embedded in cellular membranes hydrolyse other proteins and the challenges they must overcome.
Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH shares his views on data-based solutions for diabetes.
